Clinical Trial Update: Mobilization by Plerixafor of Haematopoietic Stem Cells in Children [Phase 2]

View source ↗

Summary

A Phase 2 pediatric trial evaluating mobilization of hematopoietic stem cells with plerixafor in children with solid tumors has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• Mozobil (Plerixafor) (Plerixafor)

Snippet

Sponsor: University Hospital, Clermont-Ferrand | Conditions: Children Cancer, Solid Tumor | Phase 2 | Status: COMPLETED